- Home
- / BG Medicine
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
BG Medicine financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-29
Market Capitalization
$546 K
2024-10-29
Revenue
$1.6 M
FY, 2015
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 |
|---|---|---|---|---|---|
| Revenue | 1.6M | 2.8M | 4.1M | 2.8M | 1.6M |
| Cost of goods sold | 172.0K | 841.0K | 1.2M | 956.0K | 505.0K |
| Gross profit | 1.5M | 2.0M | 2.8M | 1.8M | 1.1M |
| Gross profit margin, % | 89.5% | 70.1% | 69.4% | 65.7% | 67.8% |
| General and administrative expense | 10.5M | 7.6M | 7.1M | 4.5M | 3.6M |
| Operating expense total | 18.9M | 24.7M | 17.2M | 9.2M | 5.7M |
| EBIT | (17.5M) | (22.7M) | (14.4M) | (7.4M) | (4.6M) |
| EBIT margin, % | -1070.1% | -807.4% | -352.9% | -264.2% | -295.7% |
| Interest income | 31.0K | 22.0K | 15.0K | 2.0K | |
| Interest expense | 89.0K | 1.1M | |||
| Net Income | (17.6M) | (23.8M) | (15.8M) | (8.1M) | (5.3M) |